Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING

Identifieur interne : 004D70 ( Main/Exploration ); précédent : 004D69; suivant : 004D71

2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING

Auteurs :

Source :

RBID : ISTEX:525CB0AB84383F0EC9BA6467590F85311F2844B5

English descriptors


Url:
DOI: 10.1177/0272989X080270040104


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:525CB0AB84383F0EC9BA6467590F85311F2844B5</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1177/0272989X080270040104</idno>
<idno type="url">https://api.istex.fr/ark:/67375/M70-DPPD2M40-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002538</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002538</idno>
<idno type="wicri:Area/Istex/Curation">002538</idno>
<idno type="wicri:Area/Istex/Checkpoint">001680</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001680</idno>
<idno type="wicri:Area/Main/Merge">005080</idno>
<idno type="wicri:Area/Main/Curation">004D70</idno>
<idno type="wicri:Area/Main/Exploration">004D70</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING</title>
</analytic>
<monogr></monogr>
<series>
<title level="j">Medical Decision Making</title>
<idno type="ISSN">0272-989X</idno>
<idno type="eISSN">1552-681X</idno>
<imprint>
<publisher>Sage Publications</publisher>
<pubPlace>Sage CA: Los Angeles, CA</pubPlace>
<date type="published" when="2007-07">2007-07</date>
<biblScope unit="volume">27</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="-3">e-3</biblScope>
<biblScope unit="page" to="-4">e-4</biblScope>
</imprint>
<idno type="ISSN">0272-989X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0272-989X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>2department</term>
<term>2imperial college</term>
<term>2university</term>
<term>Abstracts conclusions</term>
<term>Abstracts methods</term>
<term>Abstracts purpose</term>
<term>Abstracts results</term>
<term>Actual decision</term>
<term>Acute infrarenal</term>
<term>Additional language versions</term>
<term>Alternative approach</term>
<term>Alternative screening strategies</term>
<term>Amsterdam</term>
<term>Analogue</term>
<term>Anchor state</term>
<term>Anesthetist</term>
<term>Annual health care expenditures</term>
<term>Antihypertensive medication</term>
<term>Appropriate diagnoses</term>
<term>Aqlq scores</term>
<term>Artery disease</term>
<term>Asthma</term>
<term>Asthma control</term>
<term>Asthma quality</term>
<term>Aston university</term>
<term>Asymmetry</term>
<term>Atrial fibrillation</term>
<term>Australia purpose</term>
<term>Autonomous decision</term>
<term>Available evidence</term>
<term>Barthel index</term>
<term>Baseline</term>
<term>Bayesian</term>
<term>Bayesian approach</term>
<term>Better asthma control</term>
<term>Better decisions</term>
<term>Bias</term>
<term>Bias term</term>
<term>Biennial european meeting</term>
<term>Biosource corporation</term>
<term>Birth weight</term>
<term>Blood pressure</term>
<term>Bootstrap approach</term>
<term>Breast cancer</term>
<term>Budget impact analysis</term>
<term>Canada purpose</term>
<term>Cancer</term>
<term>Cancer screening</term>
<term>Cardiovascular</term>
<term>Cardiovascular disease</term>
<term>Cardiovascular events</term>
<term>Carlo</term>
<term>Case study</term>
<term>Cdss</term>
<term>Center rotterdam</term>
<term>Centre</term>
<term>Cervical screening states</term>
<term>Characteristic curve</term>
<term>Chemotherapy</term>
<term>Child characteristics</term>
<term>Childhood asthma</term>
<term>Chlamydia</term>
<term>Chlamydia prevalence</term>
<term>Chlamydia screening</term>
<term>Chlamydia screening studies</term>
<term>Chlamydial infection</term>
<term>Choice experiments</term>
<term>Chronic disease management</term>
<term>Chronic diseases</term>
<term>Chronic illness</term>
<term>Chronic kidney disease</term>
<term>Clinical decisions</term>
<term>Clinical guidelines</term>
<term>Clinical outcome</term>
<term>Clinical outcomes</term>
<term>Clinical practice</term>
<term>Clinical prediction rule</term>
<term>Clinical stage</term>
<term>Clinical studies</term>
<term>Clinical trial data</term>
<term>Clinical trials</term>
<term>Clinical validity</term>
<term>Clinician</term>
<term>Coefficient</term>
<term>Cognitive</term>
<term>Cognitive process model</term>
<term>Cohort</term>
<term>Cohort model</term>
<term>Colorectal cancer</term>
<term>Common comparator</term>
<term>Common diseases</term>
<term>Competitive athletes</term>
<term>Complex task</term>
<term>Confidence intervals</term>
<term>Confidentiality</term>
<term>Confounder selection</term>
<term>Congestive heart failure</term>
<term>Consultation time</term>
<term>Content analysis</term>
<term>Context independence</term>
<term>Control group</term>
<term>Convergent validity</term>
<term>Coronary artery disease</term>
<term>Cost effectiveness</term>
<term>Cost estimates</term>
<term>Costeffectiveness analysis</term>
<term>Critical event</term>
<term>Cue</term>
<term>Current practice</term>
<term>Data collection</term>
<term>Database</term>
<term>Decision analysis</term>
<term>Decision makers</term>
<term>Decision paths</term>
<term>Decision process</term>
<term>Decision rules</term>
<term>Decision strategies</term>
<term>Decision support system</term>
<term>Decision tree</term>
<term>Decision trees</term>
<term>Decisionmaking</term>
<term>Denmark purpose</term>
<term>Depressed patients</term>
<term>Depressive patients</term>
<term>Diabetes</term>
<term>Diabetes management</term>
<term>Diagnostic accuracy</term>
<term>Diagnostic costs</term>
<term>Diagnostic decision</term>
<term>Diagnostic odds ratio</term>
<term>Diagnostic performance</term>
<term>Different approaches</term>
<term>Different causes</term>
<term>Different interview formats</term>
<term>Different results</term>
<term>Different risk formats</term>
<term>Different screening strategies</term>
<term>Different strategies</term>
<term>Different techniques</term>
<term>Differential diagnoses</term>
<term>Discrete event simulation</term>
<term>Discriminative ability</term>
<term>Disease management programs</term>
<term>Disease prognosis</term>
<term>Disease progression</term>
<term>Drug users</term>
<term>Dutch tariff</term>
<term>Dynamic model</term>
<term>East lansing</term>
<term>Ecological criterion</term>
<term>Economic appraisal</term>
<term>Economic appraisals</term>
<term>Economic data</term>
<term>Economic evaluation</term>
<term>Economic evaluations</term>
<term>Economics unit</term>
<term>Ectopic pregnancy</term>
<term>Edmunds</term>
<term>Effect size</term>
<term>Electronic databases</term>
<term>Elicitation</term>
<term>Emergency department</term>
<term>Emergency room visits</term>
<term>Endometrial cancer</term>
<term>Endoscopy</term>
<term>Endovascular</term>
<term>Endovascular repair</term>
<term>Eq5d</term>
<term>Eq5d domains</term>
<term>Eq5d tariffs</term>
<term>Erasmus</term>
<term>Eskd</term>
<term>Eskd patients</term>
<term>Ethical decision</term>
<term>Ethical principles</term>
<term>Everyday life</term>
<term>Exfoliation glaucoma</term>
<term>Expert panel</term>
<term>Expert policy</term>
<term>Extensive decision</term>
<term>Family history</term>
<term>Final model</term>
<term>First questionnaire</term>
<term>Focus group interviews</term>
<term>Framing effects</term>
<term>Framing treatment benefits</term>
<term>France purpose</term>
<term>Freiburg</term>
<term>Full information</term>
<term>Further information</term>
<term>Further research</term>
<term>General population</term>
<term>General practitioners</term>
<term>Genetic algorithms</term>
<term>Genetic counselling</term>
<term>Genetic testing</term>
<term>Glaucoma</term>
<term>Good location</term>
<term>Groningen</term>
<term>Group differences</term>
<term>Guideline</term>
<term>Hall austria purpose</term>
<term>Health care</term>
<term>Health care expenditures</term>
<term>Health economics</term>
<term>Health economics facility</term>
<term>Health outcomes</term>
<term>Health professionals</term>
<term>Health protection agency</term>
<term>Health risk information</term>
<term>Health sciences</term>
<term>Health sector</term>
<term>Health services</term>
<term>Health state</term>
<term>Health state descriptions</term>
<term>Health state valuation techniques</term>
<term>Health state valuations</term>
<term>Health states</term>
<term>Health technology assessment</term>
<term>Herd immunity</term>
<term>Heterogeneity</term>
<term>Home haemodialysis</term>
<term>Hormone therapy</term>
<term>Hospitalisation</term>
<term>Hrhpv</term>
<term>Hrhpv knowledge</term>
<term>Illicit drug</term>
<term>Illness management</term>
<term>Immunisation</term>
<term>Important role</term>
<term>Inadequate treatment</term>
<term>Incident data</term>
<term>Inclusion criteria</term>
<term>Incremental</term>
<term>Incremental cost</term>
<term>Incremental costs</term>
<term>Incremental ratio</term>
<term>Indirect costs</term>
<term>Indirect effects</term>
<term>Individualized quality</term>
<term>Indolent cancer</term>
<term>Influence diagram</term>
<term>Influenza</term>
<term>Influenza vaccination</term>
<term>Information requirements</term>
<term>Information search</term>
<term>Information visualisation</term>
<term>Insurance premiums</term>
<term>International health</term>
<term>International survey</term>
<term>Internet panel</term>
<term>Intervention group</term>
<term>Iqwig</term>
<term>James university hospital</term>
<term>Judgement</term>
<term>Judgement performance</term>
<term>Kidney check australia taskforce</term>
<term>Kidney disease</term>
<term>Kidney health australia</term>
<term>Kidney transplant</term>
<term>Kingdom purpose</term>
<term>Knowledge errors</term>
<term>Language therapists</term>
<term>Language versions</term>
<term>Large number</term>
<term>Large rearrangements</term>
<term>Latanoprost</term>
<term>Leiden</term>
<term>Leiden university</term>
<term>Life extension</term>
<term>Life utilities</term>
<term>Life weights</term>
<term>Life year</term>
<term>Life years</term>
<term>Little evidence</term>
<term>Local search methods</term>
<term>Logistic regression</term>
<term>Lower levels</term>
<term>Lung cancer</term>
<term>Maastricht university</term>
<term>Managerial decisions</term>
<term>Manchester triage system</term>
<term>Markov</term>
<term>Markov approach</term>
<term>Markov model</term>
<term>Markov models</term>
<term>Mathematical model</term>
<term>Maximum number</term>
<term>Medical decision</term>
<term>Medical decisions</term>
<term>Medical informatics</term>
<term>Medical literature</term>
<term>Medical technology assessment</term>
<term>Medication</term>
<term>Mental health professionals</term>
<term>Methodology</term>
<term>Model results</term>
<term>Model stewart stewart passmore</term>
<term>Modeling</term>
<term>Modeling uncertainty</term>
<term>Modelling</term>
<term>Monte carlo sampling</term>
<term>Morbidity</term>
<term>More accuracy</term>
<term>Mortality rates</term>
<term>Multiple objectives</term>
<term>Multivariable model</term>
<term>Mutation</term>
<term>National patient safety agency</term>
<term>Netherlands</term>
<term>Netherlands purpose</term>
<term>Norway</term>
<term>Norway purpose</term>
<term>Norwegian knowledge centre</term>
<term>Norwich university hospital</term>
<term>Novice</term>
<term>Nurse performance</term>
<term>Obese patients</term>
<term>Occupational health</term>
<term>Older patients</term>
<term>Older people</term>
<term>Oncologist</term>
<term>Open angle glaucoma</term>
<term>Open repair</term>
<term>Open surgery</term>
<term>Opportunistic</term>
<term>Opportunistic chlamydia screening</term>
<term>Opportunistic screening</term>
<term>Option</term>
<term>Organisational benefits</term>
<term>Other health professionals</term>
<term>Other measures</term>
<term>Outcome measures</term>
<term>Ovarian</term>
<term>Ovarian cancer</term>
<term>Ovarian cancer patients</term>
<term>Overall survival</term>
<term>Paediatric emergency care</term>
<term>Pandemic</term>
<term>Parameter values</term>
<term>Partner notification</term>
<term>Passive immunisation</term>
<term>Patient consultations</term>
<term>Patient involvement</term>
<term>Patient outcomes</term>
<term>Patient participation</term>
<term>Patient preferences</term>
<term>Patient safety</term>
<term>Payer perspective</term>
<term>Performance instructions</term>
<term>Perinatal period</term>
<term>Peritoneal dialysis</term>
<term>Person trade</term>
<term>Personal risk</term>
<term>Pharmaceutical product</term>
<term>Pharmaceutical research network</term>
<term>Pictorial representation</term>
<term>Plot asymmetry</term>
<term>Pneumococcal</term>
<term>Pneumococcal conjugate vaccine</term>
<term>Pneumococcal disease</term>
<term>Pneumonia</term>
<term>Policy makers</term>
<term>Population screening</term>
<term>Positive aspects</term>
<term>Positive family history</term>
<term>Positive prediction value</term>
<term>Possible reasons</term>
<term>Practitioner</term>
<term>Preference</term>
<term>Preferred information format</term>
<term>Pregnant women</term>
<term>Preliminary analyses</term>
<term>Preliminary analysis</term>
<term>Preliminary results</term>
<term>Prenatal</term>
<term>Prenatal screening</term>
<term>Present study</term>
<term>Prevalence</term>
<term>Preventive behaviour</term>
<term>Previous pandemics</term>
<term>Primary care</term>
<term>Prince alfred hospital</term>
<term>Prison reception</term>
<term>Prison vaccination</term>
<term>Process information</term>
<term>Production rules</term>
<term>Programme</term>
<term>Progression</term>
<term>Prolabels database</term>
<term>Prostaglandin analogs</term>
<term>Prostate</term>
<term>Prostate cancer</term>
<term>Proxy outcome measures</term>
<term>Psychological distress</term>
<term>Psychometric properties</term>
<term>Psychometric validation</term>
<term>Public health</term>
<term>Public health interventions</term>
<term>Publication bias</term>
<term>Qaly</term>
<term>Qalys</term>
<term>Radboud university nijmegen</term>
<term>Radiation dose</term>
<term>Radiographic pneumonia</term>
<term>Random sample</term>
<term>Randomised</term>
<term>Rasch analysis</term>
<term>Reasoning biases</term>
<term>Reference case</term>
<term>Regression analysis</term>
<term>Regression model</term>
<term>Relative risk reduction</term>
<term>Relative treatment effects</term>
<term>Reliability</term>
<term>Renal</term>
<term>Renal replacement therapy</term>
<term>Respiratory morbidity</term>
<term>Respiratory tract infections</term>
<term>Respiratory tract symptoms</term>
<term>Results show</term>
<term>Rheumatoid arthritis</term>
<term>Risk assessment</term>
<term>Risk factors</term>
<term>Risk information</term>
<term>Risk perception</term>
<term>Risk status</term>
<term>Rotavirus</term>
<term>Rotterdam</term>
<term>Routine vaccination</term>
<term>Same comparison</term>
<term>Scenario</term>
<term>Screening</term>
<term>Screening program</term>
<term>Screening strategies</term>
<term>Screening test</term>
<term>Seasonal month</term>
<term>Sensitivity analyses</term>
<term>Sensitivity analysis</term>
<term>Sequela</term>
<term>Severe side effects</term>
<term>Severe uncertainty</term>
<term>Sheffield</term>
<term>Side effects</term>
<term>Significant correlations</term>
<term>Significant impact</term>
<term>Significant reductions</term>
<term>Significant variation</term>
<term>Similar analyses</term>
<term>Simulation</term>
<term>Situation awareness</term>
<term>Smaller studies</term>
<term>Social decision</term>
<term>Social medicine</term>
<term>Societal perspective</term>
<term>Socioeconomic status</term>
<term>Southern denmark</term>
<term>Stage kidney disease</term>
<term>Standard approach</term>
<term>Standard gamble</term>
<term>Statistical modelling</term>
<term>Structural equation modelling</term>
<term>Subjective norm</term>
<term>Substitute preferences</term>
<term>Support decision</term>
<term>Support patients</term>
<term>Survival studies</term>
<term>Survival trials</term>
<term>Switzerland purpose</term>
<term>Symptom</term>
<term>Syndrome</term>
<term>Systematic review</term>
<term>Systematic reviews</term>
<term>Test characteristics</term>
<term>Test evaluation program</term>
<term>Test recommendation</term>
<term>Thematic content analysis</term>
<term>Time horizon</term>
<term>Time points</term>
<term>Time trade</term>
<term>Timolol maleate</term>
<term>Total elimination</term>
<term>Trading decision</term>
<term>Transition probabilities</term>
<term>Transmission dynamics</term>
<term>Transplant</term>
<term>Transplant registry</term>
<term>Treatment adherence</term>
<term>Treatment choices</term>
<term>Treatment decision</term>
<term>Treatment decisionmaking</term>
<term>Treatment effect</term>
<term>Treatment effects</term>
<term>Treatment options</term>
<term>Treatment questionnaire</term>
<term>Trial conditions</term>
<term>Trial participation</term>
<term>Unidimensional scale</term>
<term>Unit costs</term>
<term>University hospital</term>
<term>Unrealistic optimism</term>
<term>Unrealistic pessimism</term>
<term>Urinary symptoms</term>
<term>Useful tool</term>
<term>Usual activities</term>
<term>Utility estimates</term>
<term>Utility scores</term>
<term>Utility values</term>
<term>Utility weights</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Validation</term>
<term>Variance</term>
<term>Verbal screening</term>
<term>Visual acuity</term>
<term>Visual analogue scale</term>
<term>Website</term>
<term>Weight change</term>
<term>Weighting</term>
<term>Wider economy</term>
<term>Young people</term>
<term>Zealand dialysis</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D70 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004D70 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:525CB0AB84383F0EC9BA6467590F85311F2844B5
   |texte=   2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021